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CHAPTER I 
INTRODUCTION 
Langerhans cells are dendritic nonkeratinocytes apparently unre-
lated to melanocytes, which were first described in skin over one hundred 
years ago. They were then thought to represent a fixed population of 
peripheral nervous elements in the suprabasal layers of the epidermis 
(Langerhans, 1868). Recent studies have demonstrated lymphocyte-Langer-
hans cell interactions at sites of contact allergic reactions (Silber-
berg-Sinakin, 1978), and migration of Langerhans cells via dermal lympha-
tics to lymph nodes {Silberberg, 1975). Langerhans cells have been shown 
to possess on their cell surfaces receptors for c3 and Fe- IgG (Stingl, 
1977), !a-like antigens (Rowden, 1980), and have been demonstrated capa-
ble of presenting antigens to T lymphocytes (Braathen, 1980). The vast 
majority of scientific research concerning Langerhans cells has appeared 
in the dermatology literature. The purpose of this study is 1) to qual-
itatively compare four recent techniques of Langerhans cell detection in 
oral epithelium, 2) to quantitatively compare Langerhans cells in clin-
ically normal and clinically inflamed human gingival biopsies. 
Subjects will be selected who present with chronic periodontitis 
and display moderate to severe gingival inflammation as assessed by the 
G.I. of Loe (1967). A sextant associated with clinically inflamed tis-
sues will not be treated while the remaining teeth will be scaled and 
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root planed. Two gingival biopsies will be taken; clinically normal 
treated, and clinically inflamed untreated tissue. Langerhans cells 
cannot be identified by H&E stained sections. Histochemical and immuno-
cytochemical methods must be utilized under light microscopy. In the 
present study Langerhans cells will be specifically stained for ATPase 
(Wachstein and Meisel, 1957), HLA-DR (Rowden, 1977), S-100 (Cocchia et 
al; 1981), and OKT6 (Murphy, 1982). 
A. Studies in Dermatology 
CHAPTER II 
LITERATURE REVIEH 
In the mid 19th century, Paul Langerhans, while studying the nervous 
system, discovered a population of dendritic cells in the epidermis. He 
described them as 11 dark bodies which are very distinct from epithelial 
cells .. (Langerhans, 1868). He visualized these cells by impregnating 
human skin with gold salts, observed a suprabasal location, and noted 
that some dendrites reached upwards toward the stratum corneum, while 
others extended downward through the lower layers of the epidermis. Lan-
gerhans, however, felt that these cells were part of the nervous sytesm 
and that their dendrites reached into the dermis and connected with the 
nerve system there. His theory was maintained until the 1960's (Ferreira-
Marques, 1951; Niebauer & Sekido, 1965). During the 1950's and 1960's a 
concept which postulated a relationship between Langerhans cells and 
melanocytes predominated. Langerhans cells were then regarded as either 
previously active melanocytes (Masson, 1951), daughter cells of divid-
ing melanocytes (Zelickson, 1966), or as melanocytes in an arrested stage 
of development (Breathnach, 1963). 
Although Langerhans cells were first described more than one hundred 
years ago, they had failed to attract much attention until the 1960's. 
This may have been due, in part, to the technical difficulty of the 
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available staining techniques and to limitations of experimental methods 
to study their biologic activities. The concepts which prevailed to this 
time seemed justified and discouraged experiments to search for alterna-
tives. As investigative procedures improved and the older concepts con-
cerning this cell were challenged, general interest was revived. 
The research of the late 1960's and 1970's pointed to a mesenchymal 
origin for the Langerhans cell. Langerhans cell granules (Birbeck gran-
ules) were reported to be present in certain mesodermal tissues (Kondo, 
1969) (Hoshimo, 1970) (Breathnach, 1977). Langerhans cell granules were 
also identified in certain histocytic cells of histocytosis X, (Basset & 
Turiaf, 1965) (Cancilla:et al ., 1967) malignant cells of malignant histo-
cytosis, (Inamura, 1971) and leukemic reticuloendotheliosis (Shamoto, 1976). 
Some investigators postulated that the Langerhans cell might play a 
role in immunologic reactions and suggested that the cells might capture 
antigenic material. Hashimoto (1968) considered it to be an epidermal 
macrophage. When tracers such as peroxidase are injected in vivo into 
the skin some of the material is engulfed by Langerhans cells which in-
corporate this into their phagolysosomal system {Wolff, 1970). However, 
this research also demonstrated that keratinocytes phagocytose with much 
more vigor than the "moderately phagocytic" Langerhans cell. Phagocyto-
sis did not seem to be the major function of the Langerhans cell. 
Silberberg (1973) investigated and compared the penetration of mer-
cury in normal skin and in skin of individuals who were contact-allergic 
to mercury. She observed close apposition of lymphocytes to Langerhans 
cells at sites of contact allergic reactions while in normal skin and 
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irritant reactions there was no apposition. In a subsequent study in-
volving guinea pigs actively sensitized with 2-4-dinitro-1-chlorobenzene 
(DNBC) as opposed to control animals showed lymphocyte-Langerhans cell 
apposition as early as 3-5 hours after antigenic challenge. Langerhans 
cells were reduced in number nineteen hours after this antigenic challenge 
and seemed to be damaged. In the passively sensitized guinea pigs at the 
site of antigenic challenge~ lymphocyte-Langerhans apposition was seen 
not only in the epidermis~ but was also pronounced in the dermis where 
the Langerhans cells had increased significantly as compared to controls. 
Langerhans cells were first seen in the passively sensitized animals two 
hours after antigenic challenge. 
The findings suggested that the epidermal Langerhans cell system is 
the body's first line of defense. This cell system is well suited to pro-
tect against environmental agents since~ under normal conditions~ molecules 
of low molecular weight are the only ones able to penetrate the skin. They 
also suggested that Langerhans cells capture antigenic substances in skin~ 
circulate to a draining lymph node~ and cause specific sensitization of 
immunocompetent T cells in the node and thus they may play an important 
role in delayed-type hypersensitivity reactions. (Silberberg et al.;l976) 
Simultaneous publications by Rowden (1977) and Klareskog (1976) 
demonstrated that Langerhans cells were the only cell type in humnn epi-
dermis to express !a-like antigens.which were shown to represent HLA-DR. 
The investigators used immunofluorescence staining in their experiments. 
Ia antigen have been demonstrated to be integral for macrophage antigen-
presenting functions (Rosenthal 1978). Langerhans cells from guinea pig 
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epidermis were subsequently shown to act in vitro to present exogenous 
antigens to sensitized lymphocytes and also act as stimulator cells for 
mixed lymphocyte reactions. (Stingl, 1978) Shelley and Juhlin (1976) 
demonstrated the ability of Langerhans cells to take up contact allergens 
and proposed an antigen-trapping cell system. 
At approximately the same time, Stingl et al., (1977) concluded 
from his studies that Langerhans cells are the only epidermal cells which 
express receptors for c3 and the Fe portion of IgG. It is very unlikely 
that Langerhans cells belong to either T or B cell lineage because they 
lack the classical cell markers (E receptors and surface immunoglobulins) 
which are expressed on the majority of human (Maretta et al.; 1976) and 
guinea pig (Stingl et al.;) T and B lymphocytes (Pichler et al.; 1978). 
The surface markers present (Fc-IgG and c3) correspond to those of macro· 
phages, monocytes, and histiocytic cell types i.e. mononuclear phagocytes. 
Recent studies by Tamaki and Katz (1979,1980) have utilized the 
Langerhans cell property of bearing Ia antigens on their surfaces. These 
chimeric studies indicated that Langerhans cells were derived from a con-
tinuously replenished mobile pool of precursor cells which originate 
mostly from a bone-marrow derived cell line. 
There are many important implications to the recognition of Langer-
hans cells as epidermal macrophages. The Langerhans cell may be the 
major cell responsible for rejection of allografts in the epidermis. 
Present research suggests that the Langerhans cells are immunocompetent 
cells and function as part of the body's peripheral immune system. They 
are especially important in presentation of surface applied antigens to 
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T lymphocytes and stimulation of a subsequent immune response. These 
cells seem to have a number·of common features with cells in the monocyte-
macrophage series. 
B. Studies in Oral Mucosa 
The oral epithelium as well as the epidermis is composed predomi-
nantly of keratinocytes. There is also, however, a minority population 
of non-keratinocytes known as 11Clear cells 11 because of their appearance 
in routine paraffin-embedded material. They may be distinguished by the 
absence of desmosomal attachments to adjacent cells (Breathnach, 1980). 
These dendritic cell types include melanocytes, Merkel cells, and Langer-
hans cells, all of which may also be distinguished by the presence or 
absence of ultrastructural organelles as well as by specific light micro-
scopic techniques. All three cell types are dendritic, exhibiting 
branched cytoplasmic processes of varying dimensions. 
Melanocytes are derived from an embryonal neural crest cell popula-
tion which synthesizes melanin and transfers it to other cells of the 
epidermis or oral epithelium. The Merkel cell complex represents a slowly 
adapting mechanoreceptor, the exact mechanism of which has yet to be es-
tablished. (Iggo, 1969) Langerhans cells have been identified in the 
oral mucosa of many species (Waterhouse and Squier, 1967; Barker, 1967; 
Schroeder and Theilade, 1966; Hashimoto et al.; 1968; Sagebiel and Clarke, 
1970; Hutchens et al.; 1971; Listgarten, 1972; Hill, 1977; Burkhardt, 
1979; Newcomb, 1982). Squier (1969) demonstrated the presence of both 
melanocytes and Langerhans cells in whole epithelial she~ts of oral mu-
cosa in the rat. Szabo (1967) reported similar numbers of melanocytes 
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per square millimeter in human oral mucosa as in epidermis. He did not 
quantitate the average number of melanocytes in the various oral regions. 
Langerhans cells and melanocytes were quantitated in vestibular 
gingiva, hard palate, tongue, cheek mucosa, and the skin of the external 
lip of Rhesus monkeys ·(Hutchens et al., 1971). DOPA and osmium iodide 
reactions were used to identify basal and suprabasal dendritic cells by 
light microscope. Electron microscopy was used to confirm the presence 
of basal melanocytes and suprabasal Langerhans cells. Basal dendritic 
cells were more numerous in pigmented than unpigmented areas, but supra-
based cells did not vary with degree of pigmentation. The number of 
Langerhans cells in heavily keratinized areas such as gingiva, palate, 
and the dorsal aspect of the tongue, was significantly greater than in 
areas which appeared unkeratinized. The largest number of suprabasal 
cells was observed in the epithelium of the dorsum of the tongue. Few 
Langerhans cells were identified within the crevicular epithelium. Hut-
chens et al., suggested a direct relationship between Langerhans cells 
and the degree of keratinization. 
Hill in 1977 studied neonatal rat palatal mucosa using the ATPase 
staining reaction described by Wolf and Winklemann. He found an increase 
in epidermal Langerhans cells during the first 12 days after birth which 
appeared to remain constant from 12-33 days. Langerhans cells were iden-
tified as rounded masses of ATP positive cells with short dendritic pro-
cesses during the first two days. By four days there was a change in 
number and distribution of langerhans cells observed to the typical den-
dritic pattern. This difference may be a response to antigenic stimulation 
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or merely a functional maturation process. 
Bos and Burkardt (1979, 1980) examined interepithelial cell popu-
lations in germ free, specific pathogen-free, and conventionalized mice 
(in which an oral flora was allowed to develop) by light and electron 
microscopy. They found in the epithelium of the tongue a mean of 7.4 
cells per 1000 basal cells. After conventionalization a significant in-
crease to 14.4 interepithelial cells per 1000 basal cells was observed. 
A basal value for Langerhans cells was determined in germ free mice. Lym-
phocytes and Langerhans cells were classified and quantified solely on 
the basis of morphologic characteristics. The light microscopic tech-
niques used by this group have not been shown to be cell specific for 
Langerhans cells. Bos and Burkhardt (1980) felt that an increase in lym-
phocytes and Langerhans cells was in response to external antigenic chal-
lenge. 
The degree of keratinization of the oral epithelium has been ob-
served to decrease when gingival inflammation is present (Weinmann and 
Meyer, 1959). If there was a positive direct relationship between the 
number of Langerhans cells and the degree of keratinization the Langer-
hans cells numbers would be expected to decrease as clinical inflammation 
increases. Newcomb et al ., (1982) examined attached gingiva as plaque 
was allowed to accumulate. This group used a modification of the ATPase 
method as proposed by Juhlin and Shelley (1977). Langerhans cells ap-
peared to become more dendritic in shape after 8 days of plaque accumula-
tion than at day 0. At 21 days the same number and morphologic appearance 
was noted as at 8 days. As dental plaque accumulated adjacent to and on 
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attached gingiva there was a statistically significant increase in Langer-
hans cells in the stratum spinosum. This observation would seem to negate 
the possibility of a relationship between Langerhans cells and keratini-
zation. 
Bos and Burkhardt (1981) studying the murine oral mucosa reported 
a low mitotic rate for Langerhans cells as opposed to typical keratino-
cytes. These results were in agreement with previous studies of epidermis 
by Mackenzie (1970) and Patten (1974). These studies indicated that the 
Langerhans cells may migrate into stratified squamous epithelium of the 
skin and oral mucosa as immature progenitor cells. It also seems reason-
able that this might be a recirculating cell population in exchange with 
cells of the T-cell areas of the local lymph nodes. Necrosis of the cells 
is not logical since cells are not seen in a stage of disintegration or 
in the stratum corneum where remnance might be shed._ 
The recent research discussed has up to this point had a signifi-
cant effect on our understanding of contact allergy of the skin. Langer-
hans cells may as well play a major role in delayed hypersensitivity 
reactions of the skin and oral mucosa and changes in Langerhans cell func-
tion could be the basis of certain oral pathologic manifestations. 
C. Ultrastructural Characteristics 
~irbeck et al.; {1961) established the basic criteria which permit 
visualization with the aid of an electron microscope and distinguishes 
them from melanocytes and Keratinocytes. 
1) A clear cytoplasm 
2) A lobulated nucleus 
3) The absence of desmosomes or tonofilaments 
4) The absence of premelanosomes or melanosomes 
5) The presence of a distinct organelle now referred to as "Langerhans 
cell granule" or Birbeck granule 11 
11 
The cytoplasm of the Langerhans cell possesses all the characteris-
tics of a cell engaged in active metabolic activity and in protein syn-
thesis. Both smooth and rough endoplasms reticulum are present along 
with centrioles. Free ribosomes are of relatively inconsistent numbers 
but they are very numerous in some cells. The Langerhans cell has a well 
developed Golgi apparatus and often times two or more Golgi regions can 
be observed in one plane of section of a single cell. Typically stacked 
cisternae are found to make up this Golgi, which may be dilated and con-
sist of multiple small vesicles at its concave face and lateral margins. 
Also a variety of vesicles of different sizes are present in the cyto-
plasm and may show a fuzzy coat on the internal face of their membrane. 
The vesicles with the fuzzy coat represent cross sections of the vesicular 
portions of the Langerhans cell granules. Oblong granules have also been 
described to occur rarely with a dense matrix and a trilaminar limiting 
membrane. (VJong 1971, Ze 1 i ckson 1966) • 
Under electron microscopic observation the outlines of the cells 
are irregular but do not appear to be dendritic since the sectioning is 
rarely done through several dendrites. However, images of dendritics 
sectioned cross-sectionally or longitudinally are easily observed inter-
spersed between the keratinocytes and throughout the epidermis. (Wolf, 
12 
1972). In these sections of the epidermis the cytoplasm of the Langerhans 
cells appears relatively clear as compared to the surrounding keratino-
cytes. The cytoplasmic membrane is devoid of desmosomes although it is 
in close proximity of the membranes of adjacent keratinocytes and usually 
allows no dilation~ of the intercellular space. The nucleus is lobated 
or folded, however, round nuclei may be occasionally found. 
The most surprising feature of the cytoplasm is the absence of tono-
filaments. There are filaments of a different nature present but they 
are not always present in all parts of the cytoplasm consistently. At 
times they are regimented, ordered parallel strands and are similar to 
those found in melanocytes or macrophages. As with many of the other 
features, it has not yet been elucidated whether their occurence is vari-
able or the different tissue processing methods and stains may affect 
their visualization. 
The Langerhans Cell Granule 
The chemistry of the Langerhans cell granules has yet to be clearly 
defined. No enzymatic activity has been observed in these granules up 
to this point in time. They are stained intensely with the reaction 
product of the osmium-zinc-oxide procedure (Niebauer, 1969). Intracy-
toplasmic granules are osmium-zinc-iodide positive, however, the granules 
which have come in contact with the cytomembranes are not (Niebauer, 
1969). Niebauer assumed that it was a lipid substance responsible for 
the chemical nature of the material responsible for the metallic deposits. 
Birbeck (1961) described the granule as a rod-shaped organelle with 
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a central linear, striated density. One of the ends of the cell may ex-
hibit a partly expanded limiting membrane which has been described as re-
sembling a tennis racket (Zelickson, 1965). These forms have been pro-
posed as sectional areas of disc-shaped organelles and their vesicular 
portion as a formative stage (Birbeck, 1961). 
The most common electron microscopic picture is that of a rod-like 
profile with rounded ends and a limiting membrane approximately 60 A thick. 
The inner face of this membrane is lined by a leaflet composed of small 
particles spaced at 50-60 A intervals {Wolff, 1967). In between the lim-
iting membranes of the granule there is a linear density with a periodical 
striation which has been described as 50-50 A (Wolff, 1967; Zelickson 
1965) or as 90 A {Birbeck, 1961). It represents a lamella made up of 
electron opaque particles separated by 50-60 A wide spaces and aligned as 
two parallel lines. (Wolff, 1967). These are often continuous with vesicles 
which are located either at one end of the granule, or its center with 
rod-like profiles projecting from its circumference. The vesicular frag-
ment has a clear center and the inner side of its membrane displays a 
fuzzy coat which, in good sections seems to be organized into regularly 
spaced granular particles which appear to be similar to the particles 
lining the membrane of the rod-like portion {Wolff, 1967). 
The Langerhans cell granules appear to be distributed randomly 
within the cytoplasm but they are frequently seen in a close relationship 
with the Golgi region. The vesicles with a fuzzy internal coat are found 
interspersed between Golgi vesicles or adjacent to the lateral portions 
14 
of Golgi cisternal (Wolff, 1972). The granules also have been reported 
in the cell periphery, although less frequently. They may be attached to 
the plasma membrane with their interior opening into the intercellular 
space (Wolff, 1967); (Ze l i ckson 1965); CBreathnach 1964); (Hashimoto 1968). 
They are never, however, totally discharged into the extracellular compart-
ment. 
The granules appear as oval bodies exhibiting a two-dimensional 
square lattice of particles if cut tangentially (Birbeck & Breathnach 
1961) (Zelickson 1965). These appear to merge into a cross-striated pat-
tern in different planes of the same section. Three dimensional models 
of the Langerhans cell granules have been proposed by Wolff (1967) and 
Sagebiel (1968) and were later confirmed by Breathnach (1973) utilizing 
a freeze fracture technique and more recently by Caputo (1976) with a 
similar technique. As a result of cytolysis Langerhans cell granules 
have rarely been identified in the intercellular spaces of the epidermis 
(Wolff, 1969). Granules are not found in keratinocytes except in a situ-
ation where the entire Langerhans cell is phagocytosed by the epidermal 
cell. 
Lysosomes 
Langerhans cells have been reported to contain a variety of lysosomes 
which have been described as single membrane limited dense bodies (Breath-
nach, 1964) containing acid phosphatase (Wolff, 1970). They are lined by 
a single triple-layered membrane and contain a granular matrix, lamellae, 
whorled membranes (Breathnach, 1964) (Zelickson, 1965) or myelin-like 
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structures (Bell, 1961). Acid phosphatase is packaged in the Golgi system 
then is transferred to either autophagosomes or heterophagosomes which are 
thus transformed into secondary lysosomes. This is consistent with what 
is known concerning the lysosomal system in general. ((DeDuve, 1966). Mul-
tivesicular bodies, sacks or vacuoles which have been described intracy-
toplasmically probably belong to the lysosomal system. Often times debris 
or remnants of organelles i.e. Langerhans cell granules may be found 
(Breathnach, 1964) which would categorize these vacuoles as autolysosomes. 
D. Demonstration and Identification of Langerhans Cells 
1. Hematoxylin and Eosin 
This type of staining is of little or no value for certain identi-
fication of Langerhans cells. The cells appear in the suprabasal layers 
as high-level "clear cells" exhibiting deeply staining nuclei which is 
surrounded by apparently "clear" cytoplasm~ Keratinocytes are similarly 
stained therefore cannot be distinguished from Langerhans cells (Clark, 
1961). 
2. Gold Impregnation 
This is the classical technique most commonly employed for examina-
tion of the gross morphology and the distribution of cells. There are a 
variety of methods available, (Carey (1942); Ferreira-Narques (1951) and 
Paul Langerhans himself impregnated epidermal specimens with gold chloride. 
The characteristic dendritic shape is well visualized in a w~ll­
impregnated specimen. Little detail of the internal structures of the 
cell, however, with the exception of a nucleus can be discerned. As 
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previously mentioned there are several variations in the gold chloride im-
pregnation. These techniques, however, all have the disadvantage requir-
ing diligent preparation and inconsistent results have been reported 
(Becker, 1952). In adequately impregnated specimens this stain appears 
to be specific for Langerhans cells as verified by electron microscopy 
(Breathnach 1965; Zelickson 1968). 
3. Osmium Iodide 
The Champy-Coujard technique was utilized by Niebauer (1956), Mish-
ima and Miller Milinska (1961) and was actually considered to be more con-
sistantly reliable than gold impregnation (Miller Milinska, 1961). The 
procedure, however, is not specific for Langerhans cells since melanocytes 
or keratinocytes are also stained. Hutchins (1971) also used this method 
in examining the oral mucosa of Rhesus monkeys. The osmium iodide reac-
tion stained the entire dendritic cell black, obliterating cytoplasmic 
detail. 
4. ATPase 
For the demonstration of Langerhans cells within human, mouse, 
guinea pig and rhesus monkey epidermis the demonstration of a formalin 
resistant and sulphydryl dependent adenosine triphosphatase (ATPase) is 
a reliable and Langerhans cell-specific procedure (Jarret and Riley, 1963, 
Mustakallio (1963) Bradshaw (1963) Wolff (1962) Mackenzie and Squier 
(1975). Langerhans cells were also identified by this method in rat pa-
latal mucosa and human gingival epithelium (Hill, 1977); (Barker, 1967); 
(Waterhouse and Squier, 1967); (Newcomb, 1982). With proper techniques 
, 
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the morphologic results are good, reliable, and the stain is specific for 
Langerhans cells. This enzymatic technique does, however, have a disad-
vantage. It is not known whether all Langerhans cells react positively 
at all times and since the method depends upon enzyme activity, it may be 
influenced or inhibited in pathologic conditions. There has of yet been 
no explanation of the function of ATPase on the cell surface. An associa-
tion was made between plaque accumulation and an increase in Langerhans 
cells in human attached gingiva using the ATPase methods (Newcomb, 1982). 
A modification of the adenosine triphosphatase method has recently been 
described which involves prolonged fixation in cacodylate formalin and 
reportedly permits a more reliable visualization of cells (Robins and 
Brandon 1981). 
5. L-Dopa and Amines 
Human epidermal Langerhans cells have been reported to be capable 
of taking up L-dihydroxyphenylalanine (L-dopa) and the catecholamines 
dipamine and noradrenaline when exposed to these in vivo (Falck, 1976; 
Axelsson, 1978). A chemical reaction with formaldehyde transforms L-dopa 
and the catecholamines into strongly fluorescent molecules within the 
tissue. The dopa fluorophore of the Langerhans cell has an excitation/ 
emission which is easily distinguished from the formaldehyde-induced 
fluorophore of cysteinyldopa, a normal constituent of human melanocytes. 
This seems to be a reliable method for the visualization of Langerhans 
cells within normal epidermis. When skin biopsy specimens from antigen-
ically challenged sites of hapten-sensitized animals are treated though, 
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fluorescent clusters of both dendritic and nondendritic cells are observed. 
This suggests that different mononuclear cells uptake L-dopa and catechol-
amines (Sjoborg, 1978). 
6. a.-D r~annose 
Using the a.-D mannose technique to stain Langerhans cells the cell 
body but not the dendrites are visualized (Elleder, 1975). 
7. HLA-DR and Ia antigens 
A region of chromosome-17 of the mouse called the Ia region or im-
mune response region contains a series of genes which appear to be in-
tegral to a number of cell surface interactions related to the immune re-
sponse .. (McDevitt et al., 1976; David, 1976). Many of these Ir genes are 
capable of producing proteins on a cell surface that will be perceived as 
antigens if introduced into the body of an individual of different genetic 
background (Albert, 1977). A number of articles have recently dealt with 
the possible significance of the Ia antigens presence on Langerhans cells 
(Streilein & Bergstresser, 1980; Stingl et al., 1980a; Stringl et al., 
1980a; Stringl et al., 1980b; Rowden, 1980; Rowden, 1981). 
HLA antigens are glycoproteins on the surface of most eucaryotic 
cells. The glycoproteins are unique to the cell surface of an individual 
and enable the immune system to 11 fingerprint" a given cell as its own. 
The HLA antigens are coded for by several genes on the short arm of chro-
mosome-6 in humans is referred to as the major histocompatibility complex 
(MHC) or HLA (Albert, 1977). Humans do not produce antibodies against 
their own HLA antigens, however, they will evoke an immune response if 
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transplanted into a person of dissimilar genetic makeup. The genetic 
loci which produce HLA antigens are termed A, B, C, D and DR and their 
products HLA-A, HLA-8, HLA-C, HLA-D, and HLA-Dr. The major histocompati-
bility complex controls the reaction of animals to various immunologic 
challenges. (Sasazuki et al., 1977) Most of this immunologic activity 
may be restricted to the area of the D locus. 
HLA-DR antigens of humans and murine Ia antigens are thought to be 
analagous •. (Balner, 1979) The murine MHC has been much more extensively 
investigated because of the availability of inbred populations for study. 
Rowden et al, (1977) and Klareskog (1976) reported that Langerhans 
cells express cell surface !a-like antigens. At the present time it seems 
that only Langerhans cells or their precursors express Ia antigens on their 
cell surface. Frozen sections may be stained utilizing the appropriate 
anti-Ia antisera comercially available and a peroxidase-labeled secondary 
anti-immunoglobulin~ (Rowden, 1980) 
8. T-6 Antigen 
It has recently been reported that monoclonal antibody anti T-6 reacts 
with most immature human thymocytes, but not with circulating peripheral 
T cells. (Reinherz et al., 1980; Bahn et al., 1980) This antigen is 
present when the cells are in the thymic cortex but may be lost and ap-
parently replaced by other antigens when the cells mature into circulating 
peripheral T cells. T-6 has been identified as a glycoprotein with a 
molecular weight of 49,000 daltons. (Terhorst et al., 1981; Van Agthoven 
and Terhorst, 1982; Cotner et al., 1981) The T-6 antigen has recently 
been detected on the surface of Langerhans cells (Murphy et al., 1981; 
fithian et al ., 1981) Immune-electron microscopy has been utilized to 
confirm the specificity of T-6 for Langerhans cells in the epidermis. 
{Murphy, 1981; Murphy, 1982; Dubertret, et al.; Chu, 1982) 
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Staining is of a similar protocol as that used for HLA-DR antigens. 
Basically, frozen sections are stained with nonoclonal mouse anti T-6 
reagents, followed by goat antimouse IgG usually with a peroxidase label. 
There are now many commercailly available anti-T-6 reagents. 
9. S-100 
Moore {1965) originally extracted the S-100 protein from bovine brain at 
which time it was thought to be unique to the nervous system. It is an 
acidic calcium-binding protein (Klee et al., 1980) composed of three sub-
units, (Dannies and Levine 1971) and has a molecular weight of 21,000-
24,000 daltons. (Moore, 1965; Dannies and Levine 1971). There are several 
reviews concerning the biochemical aspects of S-100 protein (Moore, 1972; 
Bock, 1978; Isobe and Okuyame, 1978; Varon and Somjen, 1979), although 
the biologic function of the protein remains unknown. 
S-1 00 protein has been demonstrated primarily in the neurons of the· 
CNS (Hyden et al., 1966; Sriridov et al., 1972; Hansson H-A et al ., 1976), 
however, outside the CNS S-100 has only been identified in Schwann cells 
and satellite cells of the dorsal root and autonomic ganglia.(Stefansson, 
1982) 
S-100 protein has recently been reported to be present in Langerhans 
cells of normal human epidermis (Cocchia et al., 1981). The protein has 
also been identified with interdigitating reticulum cells (IDC) in the 
paracorti ca 1 zones of lymph· .nodes. (Takahashi et a 1., 1981), which a 1 ong 
with veiled ce 11 s of lymph, may be re 1 a ted to Langerhans ce 11 s ( Drexhage 
et al., 1979; Thorbecke et al., 1980; Veldman & Kaiserling, 1980; 
Hoefsmit et al ., 1~80; Hoefsmit et al.; 1982). 
Staining of epidermal Langerhans cells can be accomplished using 
' 
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either a peroxidase antiperoxidase (PAP) method (Sternberger et al., 1970; 
Sternberger, 1979) or an avidin-biotin method (Hsu et al., l98la; Hsu et 
al., l98lb). 
CHAPTER III 
MATERIALS AND METHODS 
A. SELECTION OF PATIENTS 
Thirteen adult human subjects, four females and nine males, ranging 
in age from 29 to 52 were selected for this research. They were diagnosed 
as having Type III moderate periodontitis or Type IV severe periodontitis 
according to the American Academy of periodontology's (1977) definition of 
case types. None of the patients had received a prophylaxis within the 
last six months. 
To participate in the study, the patients were required to have at 
least one area of attached, marginal, and/or papillary gingiva which dis-
played moderate to severe inflammation as assessed by the criteria of the 
Gingival Index of Loe and Silness (1963) as modified by Loe (1966). Perio-
dontal surgery was included as a possibility in the future treatment plan 
of each patient. None of the patients had a history of rheumatic fever, 
hepatitis, or other systemic complicating factors. An abscence of other 
oral pathology was also established. The females included in the study 
were neither pregnant, lactating, nor taking oral contraceptives. 
Each patient received an oral explanation of the study. It was 
explained that a portion of tissue normally discarded during routine peri-
odontal surgery would be retained for microscopic examination as part of 
a research project. This study was reviewed by the chairman of the Loyola 
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University Medical Center Institutional Review Board for the Protection 
of Human Subjects (IRB) before commencement. In reply to submission of 
a thesis outline it was decided that there was no need for IRB submission 
as long as the specimens were obtained during a surgical procedure which 
the patient undergoes for reasons unrelated to the study. Other stipula-
tions were that the specimens were not identified in terms of a patient's 
name, and the cost of the study was not billed to the patient. Patients 
were required only to sign the routine consent and permit for periodontal 
surgery used by the Loyola University School of Dentistry. 
Although thirteen subjects agreed to participate in the research, 
eleven completed therapy which included periodontal surgery. One of the 
female subjects had to be eliminated from the study because of an ex-
cellent response to initial therapy. This included scaling and curettage, 
after which periodontal surgery was not indicated as assessed at the time 
of reevaluation. After a reevaluation the patient was placed on three 
month recalls for prophylaxis as indicated, and no further periodontal 
treatment was performed. One of the male subjects withdrew from the 
dental clinic and, subsequently, the research participation. 
B. EXPERIMENTAL DESIGN 
An area in the oral cavity of each subject which showed clinical 
inflammation and was scored as GI=2 or GI=3 was left untreated until 
periodontal surgery was performed. This usually consisted of an area of 
two to three teeth and the adjacent attached, marginal, or papillary 
gingiva associated with them. In a majority of cases these teeth were 
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separated by an edentulous area from the teeth which would be treated. 
The remaining teeth were scaled and root planed. Oral hygiene instruc-
tions were initially given and were reinforced at each appointment. These 
appointments were from thirty to forty-five minutes in length and ranged 
from six to twelve weeks. Upon completion of this initial phase of 
therapy each subject•s response to initial treatment was evaluated and a 
rationale for periodontal surgery was established. The female subject 
previously discussed was withdrawn from the study at this time. The area 
which at the initial examination displayed clinical inflammation {GI=2) 
received a lower score (GI=O) at the surgical evaluation. This improve-
ment was apparently the result of improved home care. The oral tissues 
were scored at the time of the surgical evaluation and again at the surg-
ical appointment as assessed by the Gingival Index as modified by Loe 
(1966). 
PERIODONTAL SURGERY 
Blood pressure, respirations, and pulse were assessed at the begin-
ning of each surgical appointment. Anesthesia was administered using 2% 
lidocaine with 1/100,000 epinephrine. This was administered by nerve 
block whenever possible, and care was taken not to directly infiltrate 
anesthetic solution into the tissue scheduled for microscopic examination. 
The initial incision during periodontal surgery was made with a 
#15 scalpel blade approximately two millimeters from the coronal edge of 
the face marginal gingiva. The tissue coronal to this incision was care-
fully freed from the tooth surfaces and immediately placed in prepared 
vials of (RPMI). Each tissue specimen had been scored by the Gingival 
. 
Index modified by Loe (1966) immediately prior to periodontal surgery 
and placed into vials marked as 11 clinically inflamed 11 or 11 clinically 
normal 11 • Clinically normal tissue received a Gingival Index score of 
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zero. Full mucoperiosteal flaps were then reflected and routine perio-
dontal surgery was performed including osseous recontouring as indicated. 
The collar of tissue retained for microscopic examination is normally 
discarded after reflection of mucoperiosteal flaps during surgery. The 
surgical areas were sutured and protected with Coe Pak for one to two 
weeks post-operatively. There were no complications regarding surgical 
procedures or post-operation healing associated with any patients. 
The qualitative state of the gingival soft tissues were assessed 
by the Gingival Index {GI) of Loe and Silness (1963) as modified by Loe 
(1966). In the Gingival Index system of scoring oral tissues, each of 
the four gingival areas of the tooth is given a score from zero to three. 
The scores from the four areas of the tooth are added and divided by four 
to give the GI for the tooth. 
C. STAINING 
Specimens from each patient will be placed into individual vials 
marked as "clinically normaP or 11 clinically inflamed 11 • These were 
stored in RPMI for up to three hours under refrigeration at Loyola Uni-
versity Dental School. The specimens were then transported to the Path-
ology Laboratory of the Loyola University Medical Center. Each section 
was immediately divided into three sections of approximately equal length 
under a dissecting microscope. Each section was then prepared 
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specifically for the staining protocol to be utilized at a future date. 
The three different procedures were as follows: 
1. Fixed in buffered formalin for eight hours at room temperature 
Rinsed with Buffer 
Paraffin embedded for Mayers Hematoxylin and Eosin and S-100 staining 
2. Fixed in formaldyhyde-cacodylate solution for one hour at 0-4°C 
Washed in phosphate buffered saline (PBS) 
3. Frozen and stored at -80°C for future ATPase staining 
The initial ATPase staining procedure utilized was essentially a 
modification of earlier adenosine triphosphatase methods (Wachstein and 
Meisel, 1957; Juhlin and Shelley, 1977; and Mackenzie and Squier, 1975) 
which employed prolonged fixation in cacodylate formalin as described by 
Robins and Brandon (1981). The last four specimens were stained utiliz-
ing a procedure described by Wachstein et al. (1960). The staining pro-
tocol used for S-100 was a technique which entailed incubating with S-100 
antibody, antigen, and antibody (thus the name self sandwich) as described 
by Hsu and Ree (1980). 
In staining for OKT6 and HLA-DR the technique utilized was essen-
tially the same as that described by Rowden (1981). Frozen sections for 
HLA-DR were stained with the appropriate anti-IA antisera commercially 
available and a peroxidase labeled secondary immunoglobulin (Rowden (1981). 
For OKT6 the frozen sections were stained with monoclonal mouse anti T-6 
reagents, followed by goat antimouse IgG with a peroxidase label. 
D. MICROSCOPIC EXAMINATION 
A total of twenty-four tissue specimens were obtained from eleven 
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patients during periodontal surgery. After sectioning under a dissecting 
microscope and preparation as described in the previous section the slides 
were grouped for microscopic examination. Most slides included three 
serial sections from the same section and were approximately 5 microns in 
thickness. A total of fourteen slides were prepared for each of the 
eleven patients with a total of 154 slides being examined. The following 
slides were prepared and examined. 
Hematoxylin and Eosin - clinically normal 
Hematoxylin and Eosin - clinically inflamed 
ATPase - clinically normal 
ATPase - clinically inflamed 
ATPase - control 
OKT-6 - clinically normal 
OKT-6 - clinically inflamed 
OKT-6 - control 
HLA-DR - clinically normal 
HLA-DR - clinically inflamed 
HLA-DR - control 
S-100 - clinically normal 
S-100 - clinically inflamed 
S-100 - control 
The slides were examined for each of the eleven subjects with the aid of 
a Spencer light_microscope. All slides were qualitatively examined for 
the presence of Langerhans cells. The following parameters were also 
noted: 
Morphology of Langerhans Cells 
Patterns of arrangement of cells 
Presence or absence in lamina propria 
Position in epithelium 
Orientation 
Staining reactions with other cells 
Approximate numbers of cells 
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A quantative procedure was also undertaken using the sections prepared 
with the OKT-6 staining protocol. Langerhans cells were quantitated 
using aQ13 mm square standardized grid at a 400X magnification. A ran-
dom number of fields for each section were examined. OKT-6-positive 
staining cells (nuclei) were counted and a mean was established for each 
specimen. 
E. STATISTICAL ANALYSIS 
Eleven gingival specimens were obtained and stained with the OKT-6 
method described by Murphy (1981). Of the eleven specimens stained for 
Langerhans cells, seven of these were qualitatively judged acceptable 
for quantitation. The four slides that were omitted from the quantita-
tion of Langerhans cells were done so because of inconsistent sectioning. 
Staining by this method was consistent for all sections. All Langerhans 
cells were also identified in tangential sections (Fig 19), although 
quantitation was not performed because depth of the section was impossi-
ble to determine. Langerhans cells have been described traditionally in 
the suprabasal layers of the epithelium. Langerhans cell numbers were 
compared in the clinically normal gingival specimens vs. clinica_lly 
inflamed specimens. Statistic~l analysis was performed utilizing a 
students two sample T test (Fig. 27). 
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CHAPTER IV 
RESULTS 
There were no complications to the surgical procedures performed on 
the eleven patients involved with this research. Healing was uneventful 
in all cases. 
A. Hematoxylin and Eosin 
Inflammation was identified histologically in the hematoxylin and 
eosin stained sections. The clinically inflamed slide preparations were 
all easily distinguished from the clinically normal specimens. There 
were, however, different degrees of inflammation present in all the speci-
mens. The sections of clinically normal human gingiva were identified 
by the presence of intact epithelium and connective tissue in the absence 
of pathologic changes of inflammatory cell infiltrates {Fig 1 and 2). The 
sections observed in the clinically inflamed group were characterized by 
edema, and engorged capillaries in the connective tissue {Fig 3 and 4). 
An infiltrate consisting of large numbers of lymphocytes, plasma cells, 
and polymorphonuclear leukocytes was consistently observed in the clin-
ically inflamed group {Fig 3 and 4). 
B. ATPase 
A technique described by Robins and Brandon {1981) which involved 
prolonged fixation in cacodylate formalin was initially utilized (Fig 22). 
The first seven specimens were prepared in this manner in hopes of the 
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technique being an improved method as described by Robins and Brandon 
{1981). Due to technical problems of an unknown etiology, Langerhans cells 
were not identified in these sections (Fig 5 and 6). A classical ATPase 
staini·ng method described by Wachstein and Meisel (1960) was utilized for 
the final four specimens in anticipation of improved visualization of 
Langerhans cells (Fig 21). Langerhans cells were identified in sections 
stained by this technique in the stratum spinosum above the basal lamina 
(Fig 7 and 8). Although Langerhans cell nuclei were identified in these 
sections the cells were not well visualized in terms of orientation or 
morphology. Qualitatively, there seemed to be an increased number of 
Langerhans cells in the clinically inflamed group (Fig 8) in comparison 
to the clinically normal (Fig 7) Langerhans cells could only be identi-
fied in the epithelium in these sections. Blood vessels in the lamina 
propria were deeply stained obscuring any Langerhans cells which might 
have been identified (Fig 7 and 8). 
C. S-100 Protein 
A technique for staining Langerhans cells based on the presence of 
a cytoplasmic marker, S-100 protein was utilized as described by Hsu 1980 
(Fig 23). Qualitatively this proved to be a reliable cell marker and 
Langerhans cells were easily visualized. Dendrites of the cells were 
not well depicted although cell nuclei stained deeply (Fig 10 and 11). 
Qualitatively, Langerhans cell numbers seemed to be increased in the 
clinically inflamed specimens (Fig 10) in comparison to the clinically 
normal (Fig 9). Langerhans cells were observed in the lamina propria, 
although rarely. 
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D. Ia (HLA-DR) 
The staining technique for Ia (HLA-DR) utilized was described by 
Murphy (1981} (Fig 24). Langerhans cells were well stained and very 
easily distinguished from epidermal keratinocytes (Fig 13). Langerhans 
cells were most often identified in the stratum spinosum, but were occa-
sionally seen in the lamina propria. Dendrites were prominently stained 
by this method (Fig 14 and 15). The cells themselves were more easily 
identified in clinically inflamed specimens (F,ig 13). When qualitatively 
comparing clinically normal (Fig 12) to clinically inflamed (Fig 13) 
gingival biopsy sections, there seemed to be an increased number of cells 
in the clinically inflamed sections. The cells also seemed more dendritic 
and better developed morphologically (Fig 13 and 15). 
E. OKT-6 
Langerhans cells w~re well visualized in specimens prepared by a 
technique for OKT-6 described by Murphy (1981). The cells themselves 
were well differentiated with prominent dendrites and nuclei (Fig 17, 19 
and 20). Langerhans cells were most often identified within the stratum 
spinosum, although they were sometimes seen in the lamina propria. Den-
drites of the cells were observed stretching upwards towards the surface 
of the epithelium in clinically inflamed specimens (Fig 17, 20}. Langer-
hans cells seemed to form a net or continuum just below the stratum corn-
eum. Three such cells are seen in Fig 18. The dendrites of these cells 
appear to overlap although it is difficult to interpret in a two dimen-
sional representation. Langerhans cell numbers were qualitatively and 
quantitatively shown to be increased in clinically inflamed (Fig. 17 and 
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27) when compared to clinically normal (Fig 16) specimens. This was con-
firmed statistically (P = .01), and an approximate five fold increase was 
noted. This result is even more significant when one considers that only 
nuclei of epithelial Langerhans cells were counted. Although dendrites of 
Langerhans cells were observed they were not considered in the data. A 
Langerhans cell stained with OKT-6 with a prominent nucleus and dendrites 
is noted in Fig 19, which is a tangential section. 
For specimen #1 clinically normal human gingiva, the mean number of 
Langerhans cells identified in a 0.13 mm 2 microscopic field at 400X was 
0.19048 with a standard deviation of 0.397. The mean number of Langerhans 
cells observed in specimen #1 clinically inflamed in a 0.13 mm 2 micro-
scopic field was 1.200 and the standard deviation was 1.00. The increased 
numbers of Langerhans cells in the clinically inflamed group was shown by 
a student•s two sample T test to be a significant increase at 0.01. For 
specimen #2 clinically normal the mean number of Langerhans cells identi-
fied in each field was 0.33333 and the standard deviation was 0.488. The 
mean for the clinically inflamed of specimen #2 was 1.3864 and the stand-
ard deviation was 1.06. This increase was shown by a T-test significant 
at the 0.01 level. The mean number of Langerhans cells identified in a 
0.13 mm 2 microscopic field at 400X for specimen #3 clinically normal was 
0.500 with a standard deviation of 0.798. The mean for specimen #3 
clinically inflamed was 0.84615 with a standard deviation of 0.881. This 
was not shown to be a significant increase at the 0.05 level. The mean 
for specimen #4 clinically normal was 0.26786 with a standard deviation 
of 0.522. The mean for specimen #4 clinically inflamed was 0.89286 with 
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a standard deviation of 0.824. This increase was shown by a T-test to 
be statistically significant at the 0.01 level. The mean number of 
Langerhans cells identified in a 0.13 mm 2 microscopic section for speci-
men #5 clinically normal was 0.171429 with a standard deviation of 0.26. 
The mean number identified in specimen #5 clinically inflamed was 0.64286 
with a standard deviation of 0.745. This increase in the clinically in-
flamed specimen was shown to be statistically significant at the 0.01 
level. The mean number of cells identified in specimen #6 clinically 
normal was 0.12500 and the standard deviation was 0.334. For specimen 
#6 clinically inflamed the mean was 0.71429 and the standard deviation 
was 0.810. This was shown to be a statistically significant increase at 
the 0.01 level. The mean number of Langerhans cells identified in a 
0.13 mm 2 microscopic section of specimen #7 clinically normal at 400X 
was 0.42857 with a standard deviation of 0.690. The mean number identi-
fied in specimen #7 clinically inflamed was 1.4390 with a standard de-
viation of 0.976. This was shown to be a statistically significant in-
crease for the clinically inflamed specimen at the 0.01 level. 
F. Statistical Analysis 
An increase in Langerhans cell numbers was observed for all clin-
ically inflamed gingival tissue specimens when compared with clinically 
normal gingival biopsies. This was shown by a student's T test to be a 
significant increase (P = .01) in six of the seven specimens stained 
with OKT-6 (Murphy, 1981) (fig 27). Langerhans cell numbers in approxi-
mately one square millimeter of·cross sectional epithelium were estab-
lished (Table 15). Increases in Langerhans cell numbers seen in the 
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clinically inflamed gingival tissue specimens when compared to clinically 
inflamed specimens ranged from two to ten fold (Table 15). 
CHAPTER V 
DISCUSSION 
Clinical Assessment of Gingiva 
In the present study gingival tissues were assessed for degree of 
inflammation by the criteria of the Gingival Index System (Loe and Sil-
ness, 1963, Loe 1966). Inflammation was later established histologically 
in routine hematoxylin and eosin staining of specimens. Oral epithelium 
pale pink in color, stippled in texture, firm in consistency, and in the 
absence of bleeding upon probing was considered clinically normal. These 
gingival tissues received a Gingival Index score of zero. Specimens dis-
playing moderate inflammation, redness, edema and glazing, in the presence 
of bleeding upon probing received a Gingival Index score of two. All 
specimens in the present study which were considered to be clinically in-
flamed had received a score of two as assessed by the criteria of the 
Gingival Index System. (Loe and Silness, 1963, Loe 1966). Gingival tis-
sues which displayed severe inflammation, ulceration, and tendency to 
spontaneous bleeding were not included as specimens for the present study 
because of problems with preparation, and difficulty of interpretation of 
results. 
Three patients were dropped from the study prior to periodontal 
surgical procedures. Significant improvements were noted as color changes 
and probing indices. This was apparently the result of the initial phases 
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of therapy including scaling, root planing, curettage, and oral hygiene 
instruction. Clinical improvement was, however, also observed in areas 
which had received no therapy. It was assumed that this was a result of 
the oral hygiene instructions and the meticulous home care by the patients. 
These areas had received lower Gingival Index scores after the first phase 
of therapy and were then excluded from the study. 
Inflammatory infiltrates consisting of a few isolated polymorpho-
nuclear leukocytes were sometimes observed in clinically normal specimens. 
It should be kept in mind that although gingival tissues were scored as 
clinically normal due to the appearance of the oral epithelial surface, 
these tissues may have been associated with a submarginal inflammation. 
The absence of overt inflammation was confirmed for each specimen histo-
logically by examining the oral epithelial surfaces of the gingival speci-
mens. It was not established what degree of inflammation was associated 
with the depths of the periodontal pockets involved. Bleeding upon prob-
ing was not elicited in the clinically normal gingival tissue specimens. 
Crevicular fluid indices were not utilized in the present study. 
Comparison of Staining Techniques 
Specific cell surface as well as cytoplasmic markers are useful in 
identification of Langerhans cells. The cytochemical composition of 
Langerhans cells results in a variability of their reaction to the rea-
gents used in staining. OKT-6 is apparently a more reliable method of 
staining Langerhans cells than ATPase, since it relies on a specific 
antibody-antigen reaction. In addition, the use of monospecific or mono-
clonal antibodies further adds to specificity. It is not known whether 
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all Langerhans cells react positively at a given time when utilizing 
ATPase staining. The ATPase technique relies upon an enzymatic reaction 
which may be influenced by the active state of a particular cell or the 
cell of the associated pathologic conditions. Qualitatively OKT-6 was 
more efficient for staining and identification of Langerhans cells than 
ATPase in the present study, suggesting that cell surface antigenic de-
terminants identified by the antisera may be subject to variation. 
The use of S-100 protein as a cytoplasmic marker for the identifi-
cation of Langerhans cells is a newer technique and is as of yet unper-
fected. It has yet to be established which reagents are the best fixa-
tives. Therefore, the type of fixative, concentrations of fixatives, 
duration, and temperature of optimal fixation remains to be determined. 
Since OKT-6 and HLA-DR staining were achieved on essentially unperturbed 
specimens (frozen sections) such preparation artifacts were evaded. The 
S-100 protein technique is not however, without its advantages. It can 
be performed retrospectively on tissues obtained from the files of the 
pathology laboratory. As utilized in the present study S-100 protein 
seemed to be a reliable method for the identification of Langerhans 
cells in oral epitehlium. The cytoplasm and nuclei was stained to a 
much better degree than the dendrites of Langerhans cells. Clearly 
further studies are required on the parameters mentioned above before 
S-100 staining may be fully assessed with respect to efficiency versus 
staining for surface antigens such as OKT-6 and HLA-DR. 
The present study suggests that OKT-6 and Ia (HLA-DR) were 
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qualitatively the best stains for the identification of Langerhans cells 
of the reagents tested. These two techniques were very comparable in 
Langerhans cell identification properties but OKT-6 was qualitatively 
judged to be the best technique utilized. In light of other recent 
studies concerning Ia (HLA-DR), OKT-6 seems to be a more reliable marker 
for Langerhans cells. Larger numbers of OKT-6-positive cells have been 
identified in epidemics compared to HLA-DR. HLA-DR may not be cell 
specific for Langerhans cells but may be synthesized by other cells. 
(Daynes et al., 1983). Furthermore HLA-DR has also been reported to be 
present on the cell surfaces ofT lymphocytes (Evans et al., 1978) and 
on damaged keratinocytes (Lampert et al., 1981). 
The only situations in which keratinocytes have been shown to ex-
press cell surface Ia (HLA-DR) antigens are those in which some patholog-
ical process has induced some degree of peturbation or damage. In graft-
versus-host disease (Lampert et al., 1981), mycosis fungoides and lichen 
planus, (Tjernlund 1979, 1980), disturbances in the activities of the 
Langerhans cell population may be associated with an onset of Ia antigen 
synthesis by keratinocytes. Such Ia bearing keratinocytes have, however, 
not been shown to be immunologically active as judged by their capacity 
to present antigens or stimulate in a mixed lymphocyte reaction (MLR) 
(Breathnach, 1983). Whether keratinocyte presentation of Ia antigen in 
such situations is of immunological significance or is an epiphenomenon 
remains to be seen. 
An interpretation of staining reaction variability was performed 
~-
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by (Harrist et al., 1983), using monoclonal antibodies in an immunoperoxi-
dase procedure this group compared the numbers of T6-positive Langerhans 
cells with HLA-DR-positive cells in normal skin. These investigators 
concluded that intraepidermal Langerhans cells and indeterminate cells 
may be !a-positive or !a-negative. Thus, there may be a Langerhans cell 
subset which is !a-negative and T6-positive. This hypothetical subset 
would not be identified as a result of Ia (HLA-DR) staining but would 
react to OKT-6 preparation. Langerhans cell numbers were shown to be 
significantly underestimated when quantitated with Ia (HLA-DR). Harrist 
states that 11 Perhaps the Ia-positive/T6-positive subset represents an 
activated state of Langerhans cells or a functionally distinct subtype 11 
(Harrist et al., 1983). It is interesting to note that in the present 
study, sections stained with Ia (HLA-DR) and OKT-6 methods, the Langerhans 
cells seemed to be more dendritic in the clinically inflamed sections. 
The clinically inflamed specimens were most probably associated with a 
response to antigenic challenge. This finding is in agreement with the 
conclusions of Hill (1977} who examined neo-natal rat palatal mucosa and 
identified Langerhans cells as becoming more dendritic upon antigenic 
challenge. 
Langerhans Cells and Keratinization 
The dendritic morphology of Langerhans cells seems to characterize 
them as optimal immune surveilance cells due to the increased surface 
area. As an alternative, however, it has been suggested that this large 
surface area may allow distribution of controlling substances involved 
~·: 
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in keratinization (Shah et al., 1981). A role has been considered for 
Langerhans cells in the production of chalines influencing epidermal 
turnover rates (Bullough and Lawrence 1968, Sagebiel et al., 1971, Patten 
and Allen 1976). 
The T6 glycoprotein seems to be somehow related to the keratinizing 
environment. As Langerhans cells migrate from the bone marrow through 
the peripheral blood they are T6 negative. It is not until the cells 
arrive at the dermis where they are T6 negative or positive and eventu-
ally the keratinizing environment of the epidermis/oral epithelium when 
they are T6 positive. The identification of Langerhans cells with fewer 
numbers of Birbeck granules by electron microscopy may be interpreted as 
new arrivals in the process of developing into active cells. It should 
be mentioned at this point that Langerhans cells have been reported to be 
absent in certain situations of keratinization (Wolff 1972, Lessard et al. 
1968). These isolated findings however, relate to the abnormal states 
of the epidermis responding to tape stripping; therefore such findings 
are questionable. In all statements concerning the identification of 
cells of Langerhans cell morphology but lacking Birbeck granules, the 
problem of serial thin sectioning must be borne in mind. This arduous 
task has seldom been achieved so it is not certain if cells identified 
as so-called indeterminate cells (i.e. lacking Birbeck granules) really 
exist in significant numberso 
The degree of keratinization of oral epithelium diminishes in the 
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presence of gingival inflammation (Weinman and Meyer, 1959). Newcomb et 
al., (1982) demonstrated in oral epithelium an increase in Langerhans 
cell numbers as plaque accumulated. The present study demonstrated an 
increase in Langerhans cells in inflamed gingival tissues apparently sub-
jected to antigenic challenge when compared to tissues in the absence of 
clinically and histologically determined inflammation. There is always, 
however, a certain degree of inflammation associated with this tissue. 
If in fact, the degree of keratinization decreases in oral epithelium 
with inflammation, one might expect Langerhans cell numbers to decrease. 
This further confuses the role of Langerhans cells and the keratinization 
process the facts concerning the question of Langerhans cells and keratin-
ization remain unanswered at this time. 
Langerhans Cells vs. The Monocyte-Macrophage 
There have recently been the description of a number of similarities 
reported between Langerhans cells and cells of the macrophage-monocyte 
series. Among these similarities are the facts that Langerhans cells 
have adenosine triphosphatase (ATPase) activity (Wolff, 1967) and have 
the ability to migrate (Silberg, 1973). Rowden et al., {1977, 1978) and 
Klareskog et al., (1977) have conclusively demonstrated that Langerhans 
cells were the only cell in the normal human epidermis to express !a-like 
antigens which have been shown to possess HLA-DR. !a-like antigens have 
been demonstrated to be integral for macrophage-antigen presenting func-
tions (Rosenthal, 1978). Stingl (1977) furthermore, concluded from his 
studies that Langerhans cells are also the only epidermal cells which 
express receptors for C3 and the Fe portion of IgG. The same surface 
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markers are present on cells of the macrophage-monocyte series. Non-
specific esterase activity has also been linked to the Langerhans cell 
(Berman, 1979}. As previously discussed, Langerhans cells have the 
ability in vivo to actively present antigens in lymphocyte stimulation 
{Stingl, 1978}. (Katz, et al., 1980,) indicated that epidermal Langerhans 
cells were derived from a pool of precursor cells in the bone marrow. When 
considering the similarities between Langerhans cells and cells of the 
macrophage-monocyte series the finding of a mesenchymal origin for Langer-
hans is of paramount importance. 
Recently, through immunohistochemical analysis utilizing S-100 pro-
tein Langerhans cells, indeterminate {Nakajima, 1982) cells of the epi-
dermis (lacking Birbeck granules) and interdigitating cells (IDCS) in the 
paracortical area of lymph nodes were studied in dermatopathic lympha-
denitis situations. All three of these cells were included in a S-100 
positive, lysosyme-negative group. Histocytes in lymphatic sinuses were 
usually lysosyme-positive macrophages and were S-100 negative (Nakajima, 
1982). This presents a question concerning the possibility of a separate 
lineage independent of the macrophage-monocyte system. Further confirma-
tion of the heterogenicity of the macrophage series has been derived not 
only from situations where IDC's show a hyperplastic response as discussed 
above, but also in Histiocytosis X. Histiocytosis X is now considered 
as a Langerhans cell granulomatosis (Wolff, 1972), since the prominent 
atypical cell is a type of Langerhans cell as gauged by identification of 
ultrastructural Birbeck granules and the presence of T6 antigen (Murphy, 
1981, Harrist, 1983). Such cells are also S-100-positive in contrast to 
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other histiocytic disorders of the skin such as juvenile xanthogranulomas 
and reticulohistiocytomas where histiocytes and giant cells predominate 
(Rowden et al., 1983). 
Langerhans Cell Roles 
It seems unlikely that Langerhans cells function as active phago-
cytes in the epidermis or oral epithelium. It has been demonstrated that 
the surrounding keratinocytes in epithelium have the ability to phagocy-
tose many times more vigorously than Langerhans cells (Wolff, 1970). As 
such the ability of the keratinocyte to phagocytose is not surprising 
since this process is an essential step in pigment processing. What is 
surprising is that Langerhans cells if they are to be considered members 
of the MPS (macrophage phagocyte system) should perform this function so 
poorly. There seems to be little similarity between the miniscule phago-
cytic activity of the Langerhans cell and the tremendous phagocytic capa-
city of the traditional macrophage. 
Langerhans celJs have been shown to express T6 antigen, a glyco-
protein not normally associated with conventional macrophages (Murphy et 
al., 1981). This most recent finding is a further method of discriminat-
ing between dendritic cells and macrophages. What is not known is wheth-
er they represent distinct lineages or are related by functional activa-
tion of a stage in the cell cycle. 
Langerhans cells have many attributes which suit them for partici-
pation in a number of immunologic reactions. They assume a strategic 
position in the epidermis and the epithelium of the oral mucosa. This 
was confirmed for oral mucosa. They have been referred to as the 11 the 
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body's first line of immunologic defense 11 (Silberberg et al., 1975). 
Langerhans cells have also been shown to possess up to twelve dendrites, 
each of these with an immunologically reactive terminal portion (Cruick-
shank, 1975). This physical attribute gives the Langerhans cell a tre-
mendously increased surface area which would enhance its capacity for 
immune surveilance. There are other factors which when considered tend 
to point more toward Langerhans cell participation in immunologic reac-
tions. In a very short period of time Langerhans cell will present at 
the site of antigenic challenge (Silberberg et al., 1975). The same 
group demonstrated that Langerhans cells are a dynamic migrating cell 
population rather than fixed cells in the epidermis (Silberberg et al., 
1975). 
The role.of Langerhans cells in the pathogenesis of periodontitis 
is not known. However, other studies suggest such a pathway. Shelley 
and Juhlin (1976) demonstrated in guinea pigs and humans the selective 
uptake by langerhans cells of small molecules (metals, aldehydes, amines) 
which have been known to act as contact allergens. They postulated that 
Langerhans cells formed a reticuloepithelial trap indicating a close re-
lationship to the reticuloendothelial system which clears the tissue of 
antigens in the general circulation. This may in fact be analogous to 
that of the lymph node and spleen. It appears that haptens or antigens 
which are able to penetrate the stratum corneum into the avascular epi-
dermis are then trapped by the 11protective reticulum 11 of langerhans cells 
(Shelley and Juhlin, 1976). Furthermore, the presence of !a-antigens on 
the surface of such dendritic cells may be explained because of the 
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importance of genetic restriction in such antigens between antigen-pre-
senting cells and responding lymphocytes. Conventional macrophages gen-
erally phagocytose larger molecules. These observations would be com-
patable with the sugge~ted function of Langerhans cells in periodontitis. 
Langerhans cells are particularly well suited to be the first line of 
immunologic defense in the skin and chronic antigenic stimulation of the 
oral mucosa. Antigenic presentation rather than phagocytosis seems to be 
the major functional role the Langerhans cell plays in these reactions. 
Langerhans Cells in Contact Dermatitis and Periodontitis 
There is good evidence that Langerhans cells play an important role 
in allergic contact dermatitis of skin. Langerhans cells have been iden-
tified in close apposition (peripolesis) to mononuclear cells in the 
epidermis at sites of contact allergic hypersensitivity reactions (Silber-
berg 1976A). Apposition of Langerhans cells to mononuclear lymphocyte-
like cells was not observed at sites of contact primary irritant reactions. 
Two to three hours after antigenic challenge with known contact allergens 
an increase in Langerhans cells in the dermis was noted (Silberberg 1973, 
1975). Langerhans cells have been identified in the dermal lymphatics 
and in the draining lymph nodes subsequently after trapping antigens in 
the skin (Silberberg, 1976). 
Although there appears to be a constant migration of Langerhans 
cells to lymph nodes in presumably nonreactive skin, the migration of 
both Langerhans cells and indeterminate dendri.tic cells (Ioc•s) from skin 
via dermal lymphatics to draining lymph nodes is much more readily seen 
at the site of challenge after topical or intradermal challenge of 
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antigen in sensitized guinea pigs than in normal control animals. This 
migration is multiplied by a factor of 3 to 7 in immunologically reactive 
skin (Silberberg-Sinakin and Thorbecke 1980). 
Langerhans cells may have secretory functions involved in the con-
tact hypersensitivity reactions (in which they have been described) Sil-
berberg, 1973, Silberberg-Sinakin, 1976, Silberberg, 1975). A possible 
secretory function in regards to Langerhans cells function is related to 
the prostaglandin activity at sites of contact dermatitis and has been 
postulated. This activity is due to prostaglandins E and F (Goldyne et 
al., 1973, Greaves et al., 1971). The major portion of prostaglandin 
activity appears to be in the epidermis rather than in the dermis (Jou-
venaz et al., 1970, Dorp et al., 1971). The mononuclear phagocyte has 
been suggested as the principal hemopoietic cell source of prostaglandin 
E (Kurland et al., 1977, Brune et al., 1978). The formation of vacuoles 
in macrophages, resembling those seen in Langerhans cells is reported to 
coincide with prostaglandin formation and has been postulated to be the 
end result of the fusion of different cell organelles and the ensuing 
increased contact of the enzymes with their respective substrates (Bruen 
et al, 1978). Therefore if Langerhans cells represent the mononuclear 
phagocyte system in the epidermis, they are likely to be an important 
source of prostaglandins in the skin.(Silberberg-Sirakin and Thorbecke, 
1980). 
There is evidence that activated macrophages are the major source 
of prostaglandins in diseased gingiva (Loning 1980). Little support has, 
however, been given to the prostaglandin activity of the Langerhans cell 
48 
and this area is clearly in need of further investigation. 
In the present study increased number of Langerhans cells were 
shown to be present in the inflamed oral epithelium associated with perio-
dontitis. This was compared to clinically normal epithelium which was 
treated by removal of bacteria laden calculus. The increased number of 
Langerhans cells in periodontitis suggests that there may be an immuno-
logic response to plaque antigens. 
Bos and Burkhardt (1980) demonstrated that when germ free mice de-
veloped an oral flora there was a concomitant increase in epithelial 
Langerhans cells. Newcomb et al., 1982 reported in four patients that as 
plaque accumulated there was a statistically significant increase in 
Langerhans cells in the oral epithelium. The results of these studies 
demonstrated a response of oral epithelial Langerhans cells elicited upon 
antigenic stimulation and agree with the results of the present study. 
Keratinized oral epithelium such as that found in gingiva has been 
considered relatively impermeable to ingress of foreign antigens. How-
ever, certain dyes (Adams 1975) and radio-labelled substances (Haugen and 
Johansen 1975) have been shown to rapidly penetrate well into keratinized 
epithelium. It has been generally accepted that bacterial plaque anti-
gens which accumulate on the tooth surface or directly on oral epithelium 
can also penetrate this tissue and elicit a host response. As the Langer-
hans cell has been shown to increase in numbers with an increased bacter-
ial antigenic challenge and may play an integral role in the host re-
sponse, suggests that they function in the pathogenesis of periodontitis. 
In the present study, Langerhans cells were identified in the 
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lamina propria with all techniques utilized with the exception of ATPase 
due to staining of blood vessels and background staining. It was not 
determined if these cells were migrating towards the epithelium or back 
to regional lymph nodes carrying antigenic information. Although there 
appears to be a constant migration of Langerhans cells to lymph nodes in 
presumably nonreactive skin, the migration of both Langerhans cells and 
indeterminate dendritic cells (IDC's) from skin via dermal lymphatics to 
draining lymph nodes is much more readily seen at the site of challenge 
after topical or intradermal challenge of antigen in sensitized guinea 
pigs than in normal control animals. This migration is multiplied by a 
factor of 3 to 7 in immunologically reactive skin. Langerhans cells car-
rying antigen have been seen in dermal lymphatics as early as 2 hours 
after challenge. (Silberberg-Sinakin and Thorbecke, 1980). 
The increase in Langerhans cell numbers in this study seems to be 
a result of migration from the connective tissue into the epithelium. 
Kinetic investigations of Langerhans cells have shown that a very small 
number of cells are capable of proliferation within the epidermis. This 
number may be as low as 2% (Gschnait and Brenner 1979). In the absence 
of overt pathology it is generally agreed that only molecules of low 
molecular weight may pass through skin. It is also generally agreed 
upon among periodontists that plaque bacteria do not penetrate the tis-
sues during chronic periodontal disease processes. While bacteria have 
been reported in the gingiva, this occurrence is considered to be rare. 
Bacteria have been observed in gingival tissues associated with chronic 
periodontitis (Michel, 1969, Frank, 1972, Frank and Vogel, 1978) and in 
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juvenile periodontitis (Gillette and Johnson, 1982). However, the sub-
sequent host immunologic activity most likely is in response to antigens 
or haptens of bacterial plaque origin including enzymes and components 
of the bacterial cell structure. Currently, reports suggest that the 
Langerhans cell may play a role in processing foreign mo1ecu1es as pre-
viously discussed. 
In the present study Langerhans cells were significantly shown to 
be present in increased numbers in clinically inflamed gingival epithe-
lium when compared to clinically normal oral epithelium. In oral mucosa, 
it is not probable normally to develop sensitivity to a particular anti-
genic challenge; in fact one will develop tolerance. This is in contrast 
to the results of studies in allergic contact hypersensitivity of the 
skin. It is not sensible to explain these differences in host response 
in terms of different populations of cells. Rather, in the oral environ-
ment these antigenic processing cells of the epithelium are laregly 
evaded because of the binding, cleansing and actual physical "sweeping 
away" by salivary glycoproteins as well as the various enzymatic reactions 
in these secretions to which antigens are subjected. These antigens are, 
however, carried into the gastrointestinal system where a supressor mech-
anism is triggered. 
In the case of chronic stimulation as produced when densely bac-
terial laden calculus attaches to a tooth surface, a strong host immuno-
logic reaction may develop. In this situation the antigenic stimulation 
on contact with mucosa is present long enough due to the plaque and cal-
culus density representing a depot effect as opposed to being washed 
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away by the physical actions of saliva. The chronic inflammation which 
ensues and the development of sensitivity to specific bacteria may be 
amplified when host defense mechanisms are altered. Studies have shown 
both T and B cells react to antigenic challenge by blast transformation, 
lymphokine production, and antibody production. Also, circulating anti-
bodies specific for plaque organisms have been reported. Such observa-
tions support the concept of an immune response mechanism in periodontitis. 
If bacterial products (i.e., endotoxin) gains access to oral tis-
sues and presentation of the antigens by Langerhans cells takes place, 
there would be sensitization as opposed to suppression. In chronic peri-
odontal disease states there is a depot effect of potential bacterial 
antigens. This has been documented as a transitional constantly changing 
bacterial flora (Listgarten and Hellen, 1978). The flora of chronic 
periodontal disease states has been documented as changing from a rela-
tively innocous G.ram+ nonmotile predominated to a destructive Gram-
motile dominated situation. As the relative numbers of Gram- motile or-
ganisms increases along with increasing numbers of other potentially 
antigenic substances of the Gram- bacterial cell wall (i.e., endotoxin), 
the immunologic challeng~ is multiplied accordingly. 
The increase in the numbers of Langerhans cells identified in clin-
ically inflamed gingival tissues associated with periodontal disease in 
the present study may be in response to this increased immunologic chal-
lenge. This suggests that Langerhans cells are functional in the presen-
tation of bacterial plaque antigens to T lymphocytes. The T lymphocytes 
then proliferate in a response to the specific bacterial plaque antigens 
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producing lymphokines and to help B cells to produce specific circulating 
antibodies directed against the antigens. This more significant role 
postulated for the Langerhans cell is compatible with what we now know 
about the host response in chronic periodontal disease. 
The objectives of the present study were to determine which of the 
staining techniques if any were superior for the identification of Langer-
hans cells in human oral mucosa. It was determined that OKT-6 was qual-
itatively the best technique studied for this purpose. Another objective 
was to determine if there was a difference in the numbers of Langerhans 
cells present in chronically inflamed human gingiva associated with peri-
odontitis and clinically normal tissue. Langerhans cells were shown to 
be significantly increased in the chronically inflamed tissues associated 
with periodontal disease and were found in numbers averaging as many as 
five times that found in clinically normal tissue. 
CHAPTER VI 
SU~~ARY AND CONCLUSIONS 
In the present study, eleven patients were selected who presented 
with chronic periodontitis and displayed moderate to severe gingival in-
flammation as assessed by the G.I. of Loe (1967). A sextant associated 
with clinically inflamed tissues was not treated, while the remaining 
teeth were scaled and root planed. Two gingival biopsies were taken; 
clinically normal treated, and clinically inflamed untreated tissue. 
Langerhans cells cannot be identified by H&E stained sections. Histo-
chemical and immunocytochemical methods were used for staining and 
slides were examined under light microscopy. 
In the present study Langerhans cells were specifically stained 
for ATPase (Wachstein and Meisel, 1957), HLA-DR (Rowden, 1977), S-100 
Cocchia et al; 1981), and OKT6 (Murphy, 1982). Langerhans cells were 
quantitated using standardized grids in OKT6 stained sections. Approx-
imately five times as many Langerhans cells were identified in the 
standardized sections of clinically inflamed human gingiva as in clin-
ically normal gingiva of the same patient. This was shown to be a 
statistically significant increase (P = .01). 
All special stains tested were effective to some degree in demon-
strating Langerhans cells in human gingival epithelium. Of the methods 
studied, OKT6 (Murphy, 1982) was qualitatively determined to be the 
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best technique for visualization of Langerhans cells under light micro-
scopy. This technique would be recommended for future investigations 
concerning Langerhans cells in oral mucosa. The results also suggest 
that Langerhans cells may respond in chronic periodontitis by increasing 
in numbers possibly in response to dental plaque antigens. An immuno-
logic role in the host response to chronic periodontal disease is postu-
lated for Langerhans cells. 
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TABLE 1 -Specimen #1 Clinically Normal 
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TABLE 2 - Specimen #1 Clinically Inflamed 
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TABLE 3 - Specimen #2 Clinically Normal 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm 2 Microscopic Field - 60 Fields Examined 
{Section Prepared by OKT-6 Technique and Observed at 400X) 
0 0 0 1 1 
0 0 0 1 1 
0 0 0 1 1 
0 0 0 1 1 
0 0 0 1 1 
0 ;. 0 0 1 1 
' 
0 0 0 1 1 
0 0 0 1 1 
0 0 0 1 1 
0 0 0 1 1 
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TABLE 4 - Specimen #2 Clinically Inflamed 
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TABLE 5 - Specimen #3 Clinically Normal 
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0 
0 
0 
0 
0 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm 2 Microscopic Field - 36 Fields Examined 
(Section Prepared by OKT-6 Technique and Observed at 400X) 
0 0 2 
0 0 2 
0 0 2 
0 0 2 
0 1 2 
0 " 1 2 
~ 
' 
0 1 
0 1 
0 1 
0 1 
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TABLE 6 - Specimen #3 Clinically Inflamed 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm2 Microscopic Field - 52 Fields Examined 
(Section Prepared by OKT-6 Technique and Observed at 400X) 
0 0 1 2 2 
0 0 1 2 2 
0 0 1 2 
0 0 1 2 
0 1 1 2 
0 1 1 2 
,, 
' 
0 1 2 2 
0 1 2 2 
0 1 2 2 
0 1 2 2 
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TABLE 7 - Specimen #4 Clinically Normal 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm 2 Microscopic Field - 56 Fields Examined 
(Section Prepared by OKT-6 Technique and Observed at 400X) 
0 0 0 0 1 
0 0 0 0 1 
0 0 0 0 1 
0 0 0 1 1 
0 0 0 1 2 
0 :a 0 1 2 
' 
0 0 0 1 
0 0 0 1 
0 0 0 1 
0 0 0 1 
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TABLE 8 - Specimen #4 Clinically Inflamed 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm 2 Microscopic Field- 56 Fields Examined 
(Section Prepared by OKT-6 Technique and Observed at 400X) 
0 0 1 2 2 
0 0 1 2 2 
0 1 1 2 2 
0 1 1 2 2 
0 1 1 2 2 
0 1 1 2 2 
.. 
' 0 1 1 2 
0 1 1 2 
0 1 1 2 
0 1 1 2 
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TABLE 9 - Specimen #5 Clinically Normal 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm 2 Microscopic Field - 28 Fields Examined 
(Section Prepared by OKT-6 Technique and Observed at 400X) 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 1 
.. 
' 
0 1 
0 
0 
0 
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TABLE 10 - Specimen #5 Clinically Inflamed 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm 2 Microscopic Field - 28 Fields Examined 
(Section Prepared by OKT-6 Technique and Observed at 400X) 
0 
0 
0 
0 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
2 
2 
2 
2 
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TABLE 11 - Specimen #6 Clinically Normal 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm2 Microscopic Field- 46 Fields Examined 
(Section Prepared by OKT-6 Technique and Observed at 400X) 
0 0 0 1 
0 0 0 1 
0 0 0 1 
0 0 0 1 
0 0 0 1 
0 .o 0 1 
~ 
' 
0 0 0 
0 0 0 
0 0 0 
0 0 1 
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TABLE 12 - Specimen #6 Clinically Inflamed 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm 2 Microscopic Field - 28 Fields Examined 
(Section Prepared by OKT-6 Technique and Observed at 400) 
0 
0 
0 
0 
1 
1 
1 
1 
1 
1 
1 
1 
2 
2 
2 
" 2 
' 
2 
2 
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TABLE 13 - Specimen #7 Clinically Normal 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm2 Microscopic Field - 28 Fields Examined 
(Section Prepared by OKT-6 Technique and Observed at 400X) 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
1 
1 
1 
1 
1 
2 
2 
2 
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TABLE 14 - Specimen #7 Clinically Inflamed 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
Nuclei of Epithelial Langerhans Cells Identified in 
Each 0.13 mm2 Microscopic Field - 42 Fields Examined 
(Section Prepared by OKT-6 Technique and Observed at 400X) 
1 2 2 3 
1 2 2 
1 2 2 
1 2 2 
1 2 2 
1 ,2 2 
.. 
' 1 2 3 
1 2 3 
1 2 3 
2 2 3 
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TABLE 15 - Nuclei of Epithelial Langerhans Cells Anticipated 
in 1.0 mm 2 Microscopic Fields Prepared by the 
OKT-6 Technique and Observed at 400X 
Number of Langerhans Cell/ 1 mm 2 
Specimen Clinicalty Normal Clinically Inflamed 
1 1.3 7.5 
2 2.5 8.7 
3 3.0 5.5 
4 3.0 9.8 
5 1.8 6.25 
6 0.5~ 4.5 
7 1,0 5.0 
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Figure 1. Hematoxylin and Eosin (Clinically Normal) 2.5X 
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Figure 2. Hematoxylin and Eosin (Clinically Normal) lOX 
85 
Figure 3. Hematoxylin and Eosin (Clinically Inflamed) 2.5X 
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Figure 4. Hematoxylin and Eosin (Clinically Inflamed) lOX 
Figure 5. ATPase (Robins and Brandon, 1981) 
(Clinically Inflamed) 25X 
87 
Figure 6. ATPase (Robins and Brandon, 1981) 
(Clinically Inflamed) 250X 
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Figure 7. ATPase (Wachstein and Meisel, 1960) 
(Clinically Normal) 2.5X 
89 
Figure 8. ATPase (Wachstein and Meisel, 1960) 
(Clinically Inflamed) 2.5X 
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Figure 9. S-100 Protein (Clinically Normal) 2.5X 
92 
Figure 10. S-100 Protein (Clinically Inflamed) 2.5X 
93 
Figure 11. S-100 Protein (Clinically Inflamed) 250X 
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' 
Figure 12. HLA-DR (Clinically Normal) lOX 
95 
Figure 13. HLA-DR (Clinically Inflamed) lOX 
96 
Figure 14. HLA-DR (Clinically Inflamed) 25X 
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Figure 15. HLA-DR (Clinically Inflamed) 25X 
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• ' 
• 
Figure 16. OKT-6 (Clinically Normal) 2.5X 
99 
Figure 17. OKT-6 (Clinically Inflamed) 2.5X 
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Figure 18. OKT-6 (Clinically Inflamed) 25X 
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Figure 19. OKT-6 (Clinically Inflamed) 400X 
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Figure 20. OKT-6 (Clinically Inflamed) 400X 
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Fig. 21 Major Developments in the History of the Langerhans Cell 
1868 Langerhans cell discovered by Paul Langerhans - thought of as 
part of the nervous system 
1961 electron microscopic features described (Birbeck et al.) 
1966-7 Langerhans cells demonstrated in the oral epithelium (Schroeder 
and Theilade, Waterhouse and Squier) 
1967 Langerhans cell membrane shown to contain adenosine triphospha-
tase (ATPase) (Wolf and Winkelmann) 
1973 apposition (peripolesis) of lymphocytes to Langerhans cells 
demonstrated and antigen presentation by Langerhans cells 
suggested (Silberg) 
1974 migration of Langerhans cells via dermal lymphatics to lymph 
nodes described (Silberberg et al.) 
1976 11 reti cul o-epi the 1 i a 1 trap 11 for contact a 11 ergens suggested 
(Shelley and Juhlin) 
1977 cell membrane receptors for Fe fragment of IgG and complement 
{Stingl et al) and Ia histocompatibility surface antigens 
(Rowden et al., Klareskog et al., Stingl et al.) 
1978 demonstration of initiation of immune response by Langerhans 
cells (Stingl et al.) 
1982 association between plaque accumulation and Langerhans cell 
numbers in the oral epithelium of attached gingiva demonstrated 
(Newcomb et al.) 
Fig. 22 Protocol for ATPase Preparation 
(Wachstein and Meisel, 1960) 
1. Frozen sections cut at 10 microns 
2. Air dry 15 minutes - DH2o rinses 3 times 
3. ATPase solution (low heat and stir while making solution) 
0.125% ATPase 20 ml 
0.2 MpH 7.2 Tris 22 ml 
1M Magnesium Sulfate 5 ml 
2% Lead Nitrate 2.4 ml drop by drop, precipitate will occur 
4. Filter 
5. Preheat to 37°C 
(if necessary filter again) 
6. Incubate in 37°C oven 60 minutes 
7. DH2o rinse 5 times 
8. 2% ammonium sulfide - (rinse under hood until developed) 
9. DH20 rinse 5 times 
10. Aquamount 
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Fig. 23 Protocol for ATPase Preparation 
(Robins and Brandon, 1981) 
l. Fix at 0-4°C in cacodylate formalin for l hour 
i .e. distilled water 50 ml 40% formaldyhyde 10 ml 
0.2 M cacodylic acid 40 ml sucrose 6.85 g 
2. Rinse in Phosphate Buffered Saline (equal parts of 0.15 m 
phosphate buffer and 0.85% saline) 
3. Freeze and store at -80°C 
4. Frozen sections cut with cryostat to 5 ~ - 10 ~ sections 
5. Air dry several hours 
105 
6. Incubate in sections in freshly prepared, prefiltered and prewarmed 
ATP substrate at 37°C for 120 minutes (Modified Juhlin and Shelley 
(1977) substrate). 
distilled water 50 ml 
0.25 M trismaleate buffer 40 ml 
pH 7.2 
0.1 M Magnesium Sulfate 1- ml 
glucose 5 g 
adenosine-5-triphosphate 80 mg 
2% Lead Nitrate 10 ml 
pH of final solution to be 7.0 
7. Rinse in distilled water 
8. Develop in 1% ammonium sulfide until Langerhans Cells developed 
9. Rinse in tap water 
10. Aquamount 
Fig. 24 Protocol for S-100 Self Sandwich Preparation 
(Hsu, 1981) 
1. Mount 4 pro paraffin sections on prepared glued slides and dry at 
56°C 
2. Deparaffinize in 3 changes of xylene 
3. Hydrate through graded alcohols to distilled water 
4. Trypsinize 0.001 gm trypsin, 1 ml. 0.1% Cacl 2 15 minutes 
Phosphate Buffered Saline Rinse 
(equal parts of 0.15 M phosphate buffer and 0.85% saline) 
5. Block endogenous with 3% H2o2 10 minutes PBS Rinse 
6. Block endogenous with 1-5 normal swine serum 
7. Incubate S-100 AB (1-20) 30 minutes 
~ 
8. Incubate S-100 Ag 30 minutes 
(10 lambda S-100 Antigen - 1 ml PBS) 
9. Incubate S-100 AB (1-20) 30 minutes 
PBS wash 
PBS Wash 
PBS Wash 
10. Incubate swine anti-rabbit (1-20) 30 minutes PBS Wash 
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11. Incubate rabbit peroxidase antiperoxidase (1-100) 30 minutes PBS Wash 
12. Develop sites with 3,9 amino ethyl carbazole H2o wash 
13. Counterstain with Mayers hematoxylin H20 Wash 
14. Blue with saturated lithium carbonate H2o Wash 
15. Aquamount 
Fig. 25 Protocols for OKT-6 and HLA-DR Preparation 
(Murphy, 1981) 
1. Frozen section cut at 10 microns- air dry 
2. Fix in cold acetone - 30 minutes 
PBS Wash 
3. Incubate with monoclonal HLA-DR (Becton Dickinson)/ODT-6 (Ortho 
Diagnostic 60 minutes PBS Wash 
4. Incubate with rabbit antimouse peroxidase conjugated (1-10) 
60 minutes PBS Wash 
5. Develop sites with 3,9 - amino ethyl carbazole 
H2o Wash 
This step is performed qualitatively and the slide is examined 
under a microscope for the presence of Langerhans cells 
6. Counterstain with Mayers hematoxylin 
H20 Wash 
7. Blue with saturated lithium carbonate 
H2o Wash 
8. Aquamount 
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Fig. 26 Criteria for the Gingival Index System 
0 = Normal Gingiva 
1 = Mild inflammation - slight change in color, slight edema. 
No bleeding on probing. 
2 =Moderate inflammation- redness, edema and glazing. 
Bleeding on probing. 
3 = Severe inflammation - marked redness and edema, ulceration. 
Tendency to spontaneous bleeding. 
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Fig. 27 Statistical Analysis 
MEAN ST. DEV. T test 
1N 0.19048 0.397 T = -4.826 
1I 1.200 1.00 T test significant at 0.01 
2N 0.33333 0.488 T= -5.171 
21 1.3864 1.06 T test significant at 0.01 
3N 0.500 0.798 T = -1.203 
31 0.84615 0.881 Cannot reject T at 0.05 
4N 0.26786 0.522 T = -4.794 
41 0.89286 0.824 T test significant at 0.01 
5N 0.071429 0.267 .. T = -2.702 
51 0.64286 0.745 ' T test significant at 0.01 
6N 0.12500 0.334 T = -3.696 
61 0.71429 0.810 T test significant at 0.01 
7N 0.42857 0.690 T = 5.037 
71 1.4390 0.976 T test significant at 0.01 
Fig. 28 PROCEDURE 
Gingival sulcus excised 
during periodontal surgery 
Transported in RPMI culture medium 
to medical school lab 
~ 
Divided into 3 sections 
under dissecting microscope 
Fixed in buffered 
formalin for 8 hours 
at room temperature 
Buffer 
Paraffin embedded 
for H & E stain and 
S-100 
Fixed in Formaldehyde-
cacodylate solution 
for 1 hr. at 0-4°C 
Wash 
phosphate buffered saline 
Freeze and store 
-80°C 
ATPase 
staining 
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Freeze in 
isopentane liquid 
nitrogen 
HLA-DR 
and 
OKT 6 
staining 
Fig. 29 Letter to Institutional Review Board Chairman 
A Qwuw 
oTSeru1ce 
July 13, 1982 
LOYOLA UNIVERSITY 
OF CHICAGO 
SCHOOL OF DENTISTRY 
Dr. Silvio Aladjem 
Obstetrics and Gynecology 
Loyola University 
2160 S. First Avenue 
Dear Dr. Aladjem: 
2160 S. FIRST A'/ENUE 
MAYWOOD. IL 60153 
I would like to begfn a research project in the department of 
Periodontics here at Loyola University School of Dentistry. I will be 
examining sections of human gingiva obtained during surgery for the 
presence of Langerhans cells. I will be using for my study, specimens 
of human gingiva which have been removed as part of the periodontal 
surgical procedures used in the routine treatment of periodontal disease. 
The patients will be required to sign the attached consent form 
as do all patients who have periodontal surgery performed here. I have 
added one sentence to be more specific towards my research. 
These tissues are commonly stained by many techniques as will be 
done in my study. I therefore would like to request an expedited review 
since there is minimal risk to the patient, the surgical procedures will 
not be altered in any way from that normally used, and the procedure has 
been used previously in other research projects. · 
Respectfully, 
Charles DiFranco, D.D.S. 
Dept. of Periodontics 
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Fig. 30 Reply from Institutional Review 
Board Chairman 
LOYOLA UNIVEHSITY i\IEIJlCAI., CENTEH 
2160 Suuth fo·iut Avconue. MO\Y\\'C>('Od, lllinni:c fi015.1 
July 14, 1982 
Charles DiFranco, D.D.S. 
Department of Periodontics 
Dental School 
Loyola University School of Dentistry 
Dear Dr. DiFranco: 
312 5l1·3000 
In reply to your letter of July 13, 1982, as long as the 
specimen is obtained during a surgical procedure which the 
patient undergoes for reasons unrelated to your study, and 
as long as the specimen is not identified in terms of a 
patient's name, there is no need for IRB submission. This 
falls under the category of studies of pathologic tissue. 
There is no need to !nclude the added underlined sentence 
in the consent form. It should also be clear that the cost 
of your study should not be billed to the patient. 
Thank you for consulting the Board in this matter. 
( 
Sin<<<oly, \ 
Si lvi~~j l':~\~ni <nnn 
' \ Institutlonal Revie~ Board for the 
Protectio'n of Human ~ubjects - Hedical Center 
SA/s 
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Fig. 31 CONSENT AND PERMIT FOR PERIODONTAL SURGERY 
Patient Age ____ _ 
Place: Loyola University 
School of Dentistry 
May1~ood, I 11 i noi s 
Date ____ _ 
Time ____ _ 
1. Thereby consent, authorize and r~quest· the Department of Periodontics, Loyola 
University, Haywood, Illinois to perform periodontal surgery and all other 
necessary therapeutic surgical procedures, which have been prescribed to me. 
2. I also consent, authorize and request the administration of such anesthetic 
or medication as may be deemed advisable for the procedure. The nature, purpose 
and risk of the anesthetic or medications and possible alternative methods of 
anesthesia and medication have been explained to me. I acknowledge that no 
guarantee or assurance has been made as to the results of said anesthetics 
or medications. 
3. If any unforseen condition ari1ses in the course of this procedure calling in 
the judgement of the therapist for surgical or nonsurgical procedures in 
addition to those now contemplated, I further request and authorize him to 
do whatever he deems advisable and necessary in the circumstances. 
4. I have been informed that periodontal surgery is intended to extend the length 
of tooth retention and that no prognosis can be designated to each tooth and 
that teeth having a questionable prognosis may require extraction after a 
surgical evaluation. 
5. I am aware of the aesthetic ·appearance (gingival recession with root exposure) 
which may be necessary in order to obtain a good periodontal result. 
6. I have been informed of possible post periodontal root sensitivity. 
7. It has been explained that I must maintain diligent and consistent home care, 
obtain frequent cleanings and proper oral rehabilitation in order to increase 
tooth longevity. 
8. The nature and purpose of the procedure and possible alternative methods of 
treatment, have been explained to me. Further, I consent to the disposal of 
any tissue which may be removed unless otherwise requested by me to be 
examined by a pathologist. I consent to having any tissues which may be 
removed to be examined for the presence of Langerhans cells. 
9. If the patient is under 18 years of age, his or her parent or guardian must 
sign below and thereby accept and agree to the foregoing on behalf of 
himself or herself and his child or ward. 
The above has been read and understood by me. I accept responsibility for said 
content. 
(Resident or Attending Dentist) \Patient or Guardian) 
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